TrialDrug design, development and therapy2021

Bioequivalence and Pharmacokinetic Evaluation of Two Oral Formulations of Regorafenib: An Open-Label, Randomised, Single-Dose, Two-Period, Two-Way Crossover Clinical Trial in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Qian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.